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ABSTRACT
Fibrillar collagen type 1 is the most abundant type of collagen within the body and is a critical component of extracel-
lular infrastructure. In order to assess collagen synthesis and extracellular accumulation in fibrotic disorders, improved 
methods are needed to detect changes in procollagen versus mature collagen at the protein level. Using Western blot 
methodology, we systematically examined: (1) gel composition (Tris-glycine vs. bis-Tris, gradient vs. non-gradient, 
sodium dodecyl sulfate (SDS) vs. no SDS); (2) sample preparation (SDS vs. no SDS, β-mercaptoethanol (BME) vs. no 
BME, boiling vs. no boiling); and (3) running buffer composition (SDS vs. no SDS). Our results indicate full native gel 
conditions prevent resolution of all collagen type 1 bands. The best resolution of type 1 procollagens is achieved using 
4%–12% Tris-glycine gels without the presence of SDS in the gel itself, although SDS in the running and sample buffers 
are needed. Also, BME must not be added to the sample buffer and samples should not be boiled. For characterization of 
mature collagen 1(I), both 8% and gradients type gels are appropriate, although still without SDS, yet with SDS included 
in both running and sample buffers, BME must be added to the sample buffer, and samples should not be boiled. Boiling 
is to be avoided as the antigenic site recognized by the monoclonal antibody used is sensitive to thermal denaturation, 
as is the case with many monoclonal antibodies available on the market. Thus, the exact parameters employed are 
dependent upon the collagen protein product that the scientist desires to identify.
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BACKGROUND
A key goal of our lab is to examine mechanisms underlying over-
use-induced muscle, tendon and nerve fibrosis and effective treatments 
for these pathological tissue changes [1-3]. Excessive deposition of 
extracellular matrix is also associated with other disorders, such as patho-
logical mechanical overload of the heart [4]. Western blot methods are 
needed to detect changes in collagen type 1 protein synthesis, in which 
synthesis of intracellular procollagen products might increase more than 
extracellular mature collagen [5]. Therefore, the focus of this protocol 
is on western blot characterization of collagen type 1 chain subtypes.
Collagen is known to be derived from a larger precursor that is 
subsequently modified via cleavage events to smaller derivatives, 
which can vary between tissues and during different physiological 
circumstances depending on the relative rates of biosynthesis and deg-
radation [6]. As shown in Figure 1, collagen I precursors are complex 
proteins composed of three polypeptide chains called α chains (two α1 
chains and one α2 chain) wound together in a right handed triple helix. 
The intact disulfide bonded collagen type 1 has a molecular weight 
range of ~250 and higher under non-reduced conditions (no BME) [7]. 
The observed molecular weight ranges of procollagen a1(I) and a2(I) 
chains are ~140–200 kDa [1,3,5,7,8]. Cleavage of first the N-terminus 
propeptide and then the C-terminus propeptide yields mature collagen 
a1(I) and a2(I) (~100 to 140 kDa dependent on tissue type, preparation 
and assessment conditions) [3,5,7,9,10]. Collagen a1(I) and a2(I) from 
which the N- and C-terminals have been removed are secreted and 
function as the building block for collagen fibril formation [11]. Further 
processing produces cleaved collagen I products that range between 
~50–80 kDa in muscles [6,8].
Many manufacturer protocols and antibody sheets currently provid-
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ed for collagen visualization using Western blot methods recommend 
using either non-thermally denatured samples or all-native immunoblot 
conditions (no β-mercaptoethanol (BME), no boiling and no SDS). 
However, we have found that characterization of pro and mature col-
lagen is not possible on a purely native-conditioned western (as we 
will show in Fig. 2). Compounding the problem is that immunoblots 
shown in the literature are often trimmed to show only one molecular 
weight band, although several bands can be visualized in a whole 
Western blot [1,3,5,7,8].
Figure 1. Schematic diagram of rat collagen type 1 biosynthesis. The stages of maturation and the cleaved products (shown as breaks in the chains) 
of the individual a1 and a2 peptides together with their amino acid (AA) sequence lengths are shown. The trimer polypeptides formed are also illustrated.
The necessity of an updated step-by-step protocol for the characteri-
zation of procollagen type 1 versus mature collagen protein expression 
is paramount for our research question. To this end, we systematically 
examined: (1) gel composition (Tris-glycine vs. bis-Tris, gradient vs. 
non-gradient, SDS vs. no SDS); (2) sample preparation (SDS vs. no 
SDS, BME vs. no BME, boiling vs. no boiling); and (3) running buffer 
composition (SDS vs. no SDS). We used a monoclonal antibody directed 
against procollagen type 1 (Sigma #C2456 anti-collagen type 1, clone 
Col-1 also available from other suppliers) since we have successfully 
used it for both immunohistochemistry and western blot analyses 
[1-3], despite manufacturer’s suggestions that it is best used for only 
immunohistochemistry and dot blot. With these different approaches, 
we explore which combination allows clearest detection of procolla-
gen bands versus mature collagen bands needed to identify changes in 
collagen synthesis in future studies, and which method combination 
might allow detection of both procollagen and mature collagen subtypes.
MATERIALS
Tissues
Soleus skeletal muscles from young adult female Sprague-Dawley 
rats (3 months of age at onset of experiments) were used (Charles 
Rivers, Wilmington, MA).
Reagents
Tissue homogenization
 9 PBS (phosphate buffered saline), without calcium and mag-
nesium, 1×, pH 7.4 (Fisher Scientific, cat. #MT21040CV, 
Waltham, MA)
 9 Lysis buffer (see Recipes, made fresh immediately before 
homogenization and stored on ice)
 9 Pierce™ Protease Inhibitor Tablets, EDTA-Free (Thermo 
Scientific™, cat. #A32965, Waltham, MA)
 9 1.5 ml Micro Centrifuge Tube, Sterile (Cell Treat, cat. #229443, 
Peperell, MA)
 9 Conical Tubes, 15 ml (Invitrogen™, cat. #AM12500, Carls-
bad, CA)
 9 70% ethanol
Protein quantification
 9 Pierce™ BCA Protein Assay Kit (Thermo Scientific™, cat. 
#23225, Waltham, MA)
 9 Costar 96-Well Flat-Bottom EIA Plate (Bio-Rad, cat. #2240096, 
Hercules, CA)
Sample preparation
 9 Collagen I, Rat Tail (Purified Protein, 3 mg/ml) (Gibco®, cat. 
#A10483-01, Carlsbad, CA)
 9 4× Laemmli Sample Buffer (Bio-Rad, cat. #161-0747, Her-
cules, CA)
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 9 Novex™ Tris-Glycine Native Sample Buffer (2×) (Invitro-
gen™, cat. #LC2673, Carlsbad, CA)
 9 β-mercaptoethanol (Fisher BioReagents®, cat. #BP176-100, 
Fair Lawn, NJ)
 9 Lysis buffer (see Recipes)
 9 Sample/protein of interest
Gel preparation
 9 Western Blotting Filter Paper, 7 cm × 8.4 cm (Thermo Sci-
entific™, cat. #84783, Waltham, MA)
 9 30% Acrylamide/Bis Solution 29:1 (Bio-Rad, cat. #1610156, 
Hercules, CA)
 9 Tris-Base (Fisher Bioreagents®, cat. #BP152-5, Fair Lawn, NJ)
 9 6 N HCl (FisherChemical, cat. #SA56-500, Fair Lawn, NJ)
 9 Sodium dodecyl sulfate (SDS), white powder (Fisher BioRe-
agents™, cat. #BP166-500, Fair Lawn, NJ)
 9 Ammonium Persulfate (Sigma-Aldrich, cat. #A3678-25G, 
St. Louis, MO)
 9 TEMED (Bio-Rad, cat. #1610800, Hercules, CA)
 9 SureCast™ Gel Handcast Station (Invitrogen™, cat. #HC1000, 
Carlsbad, CA)
 9 SureCast™ Glass Plates (Invitrogen™, cat. #HC1001, Carls-
bad, CA)
 9 SureCast™ Gel Spacer (Invitrogen™, cat. #HC1003, Carls-
bad, CA)
 9 1.0 mm 10-Well, 12-Well or 15-Well Combs (Novex®, cat. 
#NC3010, NC3012, NC3015, Carlsbad, CA)
 9 2-Propanol (also known as isopropyl alcohol) (Fisher Chemical, 
cat. #A416-500, Fair Lawn, NJ)
 9 diH
2
0
Gel electrophoresis
 9 Novex™ 4%–12% Tris-Glycine Mini Gels, WedgeWell™ 
format, 10-well (Invitrogen™, cat. #XP04120BOX, Carlsbad, 
CA, store at 4°C for up to 1 year)
 9 NuPAGE™ 4%–12% Bis-Tris Protein Gels, 1.5 mm, 10-well 
(Invitrogen™, cat. #NP0335BOX, Carlsbad, CA, store at 4°C 
for up to 1 year)
 9 iBright™ Pre-stained Protein Ladder (Invitrogen™, cat. 
#LC5615, Waltham, MA)
 9 NativeMark™ Unstained Protein Standard (Novex®, cat. 
#LC0725, Carlsbad, CA)
 9 Tris base (Fisher BioReagents™, cat. #BP152-5, Fair Lawn, 
NJ)
 9 Glycine (Fisher Bioreagents™, cat. #BP381-5, Fair Lawn, NJ)
 9 Sodium dodecyl sulfate (SDS) (Fisher BioReagents™, cat. 
#BP166-500, Fair Lawn, NJ)
 9 1× Tris-glycine running buffer (with or without SDS) (See Rec-
ipes) NuPAGE™ MOPS SDS Running Buffer (20×), diluted 
to 1× with diH
2
0 (Invitrogen™, cat. # NP0001, Carlsbad, CA)
 9 Gel Loading Tips 1–200 µl (Fisherbrand™, cat. #02-707-181, 
San Diego, CA)
Immunoprecipitation
 9 Pierce™ Classic IP Kit (ThermoFisher™, cat. #26146, Rock-
ford, IL)
 9 Anti-Collagen I, polyclonal rabbit (Abcam, cat. #ab34710, 
Cambridge, MA)
 9 Tris, 1.0 M buffer soln., pH 9.5 (Alfa Aesar™, cat. #AA-
J62084K2, Ward Hill, MA)
Electrophoretic blotting
 9 1× Tris-glycine transfer buffer (See Recipes, store at 4°C)
 9 AmershamTM ProtranTM 0.2 µm NC Nitrocellulose Blotting 
Membrane (GE Healthcare Life Science, cat. #10600011, 
Germany)
 9 Western Blot Roller (Thermo Scientific™, cat. #84747, 
Waltham, MA)
 9 Excelta™ Plastic tweezers (Fisher Scientific, cat. #17-467-
347, Fair Lawn, NJ)
 9 SureCast™ Multi-use Tool (Invitrogen™, cat. #HC1010, 
Waltham, MA)
 9 Ponceau S solution (Sigma-Aldrich, cat. #P7170-1L, St. Louis, 
MO)
 9 Hanks’ Balanced Salt Solution (HBSS), 1× (Gibco® by Life 
Technologies, cat. #14175-079, Grand Island, NY)
Antibody incubation
 9 Anti-Collagen, type 1, monoclonal mouse (Sigma-Aldrich, 
cat. #C2456, St. Louis, MO)
 9 Beta Tubulin Polyclonal Antibody, (ThermoFisher™, cat. 
#PA1-16947, Rockford, IL, used at 1:1000)
 9 IRDye® 800CW Goat Anti-Mouse (LI-COR®, cat. #925-32210, 
Lincoln, NE)
 9 IRDye® 800CW Goat Anti-Rabbit (LI-COR®, cat. #926-32211, 
Lincoln, NE)
 9 IRDye® 680RD Goat Anti-Rabbit (LI-COR®, cat. #926-68071, 
Lincoln, NE)
 9 Bovine Serum Albumin (BSA), Fraction V, Cold-ethanol 
Precipitated (Fisher BioReagents™, cat. #BP1605-100, Fair 
Lawn, NJ, store at 4°C)
 9 Tween® 20 (Sigma Aldrich, cat. #P1379, St. Louis, MO, very 
viscous liquid so pipette very slowly to not draw any air)
 9 Black Western Blot Incubation Boxes (LI-COR®, cat. #929-
97201, Lincoln, NE)
Recipes
 9 Lysis buffer (made fresh daily): Pierce protease inhibitor, 
EDTA-Free 1 tablet, PBS 50 ml, disssolve by vortexing
 9 10% APS (made fresh daily): Ammonium persulfate 0.10 g, 
diH
2
O 1 ml, dissolve by vortexing
 9 1.5 M Tris-HCl, pH 8.8 (150 ml): Tris base 27.23 g, diH
2
O 80 
ml, adjust to pH 8.8 with 6 N HCl, diH
2
O to 150 ml
 9 0.5 M Tris-HCl, pH 7.6 (100 ml): Tris base 6.00 g, diH
2
O 60 
ml, adjust to pH 7.6 with 6 N HCl, diH
2
O to 100 ml
 9 10% SDS (10 ml): SDS 1.00 g; diH
2
O 9 ml, dissolve with 
gentle stirring, diH
2
0 to 10 ml
 9 10× SDS-PAGE running buffer (1 L): Tris base 30.30 g, 
glycine 144.10, SDS 10.00 g, diH
2
O to 1 L. For 1×, mix 100 
ml with 900 ml diH
2
0.
 9 10× native PAGE running buffer (1 L): Tris base 30.30 g, 
glycine 144.10 g, diH
2
O to 1 L. For 1×, mix 100 ml with 
900 ml diH
2
0.
 9 10× PAGE transfer buffer (1 L): Tris base 105.0 g, Glycine 
27.5 g, diH
2
O to 1 L. For 1×, mix 100 ml with 800 ml cold 
diH
2
0 and 100 ml methanol.
 9 10× TBS (1 L): Tris Base 24.2 g, NaCl 80 g, diH
2
O to 1 L. 
For 1×, mix 100 ml with 900 ml diH
2
0.
 9 1× washing buffer (TBST): 10× TBS 100 ml, Tween 20 1 
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ml, diH
2
O to 1 L
 9 Blocking buffer (5% BSA in TBST): 1× washing buffer (TBST) 
100 ml, BSA (in 4°C fridge) 5 g. Allow to sit at 4°C for ~15 
min to mix before using.
 9 Ponceau S staining buffer, 1:10 (50 ml): Ponceau S solution 
5 ml, dH
2
O 45 ml
Equipment
 9 –20°C freezer
 9 –80°C freezer
 9 Hot Plate (set to 100°C)
 9 Homogenizer VDI 12 (VWR™, cat. #431-0125, Radnor, PA)
 9 2 VWR™ Platform Rocking Shaker 100 115V (Store one at 
RT and one at 4°C, VWR™, cat. #VWRU40000-300)
 9 Eppendorf® Microcentrifuge 5415 D placed in a 4°C refriger-
ator (Sigma-Aldrich, cat. #Z604062, St. Louis, MO)
 9 Vortexer
 9 Shaking 37°C incubator
 9 PowerEase™ 300W Power Supply (Thermo Fisher Scientif-
ic™, cat. #PS0300, Waltham, MA)
 9 iMark™ Microplate Absorbance Reader (Bio-Rad, cat. 
#1681130, Hercules, CA)
 9 SureCast Handcast System (Invitrogen™, cat. #HC1000S, 
Waltham, MA)
 9 Mini Gel Tank (Invitrogen™, cat. #A25977, Waltham, MA)
 9 Mini Blot Module (Invitrogen™, cat. #B1000, Waltham, MA)
 9 Odyssey Classic Infrared Imaging System (LI-COR®, cat. 
#980-11174, Lincoln, NE)
PROCEDURES
Tissue homogenization
1. Keep tissue in a sterile 15 ml conical tube on ice.
2. Prepare fresh lysis buffer and keep on ice.
3. Add 1.0 ml lysis buffer to the conical tube with the tissue and allow to sit for 15 min.
4. Assemble the homogenizer and sterilize by rinsing 3 times in 70% ethanol, then 2 times in PBS.
5. Turn on the homogenizer for a maximum of 5–10 s at a time to homogenize the tissue without overheating. 
Keep samples on ice during this step.
TIP: Sterile tweezers may be used to remove unhomogenized pieces stuck on the tip of the homogenization tool 
and place back at the bottom of the conical tube.
6. Once the sample is completely homogenized and in a mostly liquid-like state, transfer the sample to a sterile 
Eppendorf tube.
TIP: If some sample is still left in the conical tube, add more lysis buffer (0.3–0.5 ml) to complete transfer.
7. Rotate samples in a rotating rack for 15–30 min at 4°C.
8. Centrifuge at 12000 RPM for 15 min at 4°C.
9. Pipette off the supernatant into a sterile Eppendorf tube.
NOTE: This is the protein sample of interest.
CRITICAL STEP: To avoid freeze-thaw, aliquot samples immediately and use. For future use, store the aliquots 
at −80°C. Degradation can occur, so keep the number of freeze-thaws to as few as possible.
Protein quantification
10. Follow Pierce™ BCA Protein Assay kit’s instructions.
11. Use the acquired protein concentration to calculate the number of µl of protein sample containing 20 µg total 
protein to be loaded into each well.
Gel preparation
12. Preparation of separating gel:
12.1. Assemble glass plates with rubber divider in casting stand (ensure clean by washing first with soap 
& water, then 70% ethanol) and tilt the casting stand backward.
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12.2. In a 50 ml conical tube, combine the following reagents for an 8% Tris-glycine gel (include SDS for 
SDS-PAGE; exclude SDS for NATIVE-PAGE and replace with diH
2
0). Add TEMED last (dH
2
O 9.3 
ml, 30% acrylamide 5.3 ml, Tris-HCl (1.5 M) 5.0 ml, SDS (10%) 0.2 ml, 10% APS (fresh) 0.2 ml, 
TEMED 0.012 ml).
12.3. Gently mix the tube by inverting slowly to avoid introducing air bubbles as oxygen inhibits polym-
erization.
TIP: Only a few times because it polymerizes quickly.
12.4. Slowly transfer approximately ~8 ml of the solution or until it reaches the “fill line” on the plate 
and no more than 10 ml, into the gap between the glass plates to avoid forming gas bubbles using a 
serological pipette.
12.5. Top the gel off with a layer of isopropyl alcohol to limit contact with air and to remove air bubbles 
that may have formed when pouring the gel.
12.6. Allow the gel to polymerize (20–30 min).
TIP: Placing a plastic bulb pipette into the left over solution allows the observation of the polymerization of the 
finished gel without touching the actual gel itself.
13. Preparation of stacking gel:
13.1. Use filter paper to soak up the isopropyl alcohol that is above the separating gel.
13.2. 13.2 In a 50 ml conical tube, combine the following reagents for an 8% Tris-Glycine Gel (include 
SDS for SDS-PAGE, or exclude SDS for NATIVE-PAGE and replace with diH
2
0). Add TEMED last 
(dH
2
O 5.5 ml, 30% Acrylamide 1.3 ml, Tris-HCl (0.5 M) 1.0 ml, SDS (10%) 0.08 ml, and 10% APS 
(fresh) 0.08 ml TEMED 0.008 ml). 13.3 Gently mix the tube by inverting slowing (only a few times).
13.3. Slowly transfer approximately 3 ml of the solution into the gap between the glass plates to avoid 
forming gas bubbles.
13.4. Insert the comb at a slight angle and allow the gel to polymerize for about 20 min. If bubbles form 
around the comb, remove it and replace it again.
NOTE: Gel preparation is not necessary if using pre-casted gels, such as Novex™ 4%–12% Tris-glycine mini gels.
Gel electrophoresis
14. Turn on the heat plate.
15. Thaw protein samples on ice.
16. If the protein concentration of one’s sample is known, proceed to next step. If not, follow “Protein quan-
tification.” For nonreducing conditions, steps 17–23 can be altered to exclude the reducing agent (BME).
17. Calculate the combined amounts of [sample buffer + BME] and [protein sample + lysis buffer] based on the 
desired total volume loaded into each tube (this protocol recommends 20 µl) and concentration of the sample 
buffer. For 4× sample buffer: combine 1 part [4× sample buffer + BME] with 3 parts [protein sample + lysis 
buffer]. Example: Total µl = 20 µl; 1/4 (20) = 5 µl = [sample buffer + BME]; 3/4 (20) = 15 µl = [sample + 
dilutant].
18. Calculate the individual amounts of sample buffer and BME necessary to make the combination calculated 
in step 17. This protocol recommends a 10% BME in sample buffer solution, which can be made by combing 
1 part BME with 9 parts sample buffer. Example: 1/10 (5) = 0.5 µl = BME; 9/10 (5) = 4.5 µl sample buffer.
19. Calculate the individual volumes of protein sample and lysis buffer necessary to make the combination 
calculated in step 17. Example: 15 µl−Vsample = 15−3.62 = 11.38 µl lysis buffer.
20. Create a table as illustrated below (Table 1), including the numbers assigned to each lane.
21. Place the cassette clamps into the electrophoresis chamber, insert the gel(s), clamp, fill with running buffer 
to fill line, and remove the gel comb slowly and straight up.
22. Prepare individual solutions for each well in separate Eppendorf tubes. Add [BME + sample buffer] last.
23. Vortex and spin down the samples.
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24. Boil the samples (if desired) at 100°C for 5 min.
25. Load 2 µl of iBright Fluorescent Marker into 1 or more lane.
26. Load the protein sample solutions into the other lanes.
27. Run the gel on constant mode at 125 V for handcast gels, 225 V for Novex 4%–12% Tris-Glycine precast 
gels, OR 200 V for NuPAGE™ 4%–12% Bis-Tris Protein Gels. Once the settings are correct and lid is se-
cure, one can then hit “run”.
NOTE: Watch the gel, as exact running time will vary.
28. When the gel is finished running, turn off the power supply and remove the lid.
29. Remove cassette, separate the 2 sides of the gel (be careful not to rip the gel), nick the top left corner of the 
gel, and trim the top and bottom using the SureCast Multiuse Tool.
Table 1. Example calculations for total volume and individual volumes of protein sample, lysis buffer, BME, and sample buffer to be loaded into 
each well.
Lane Conditions VSample (µl) VLysis buffer (µl) VBME (µl) V4× sample buffer (µl) VTotal (µl)
1 Marker 2 0 0 0 2
2 BME + boiled 3.62 11.38 0.5 4.5 20
3 BME + Not boiled 3.62 11.38 0.5 4.5 20
4 No BME + boiled 3.62 11.38 0 5 20
5 No BME + Not boiled 3.62 11.38 0 5 20
6 +-Control: BME + boiled 2 13 0.5 4.5 20
7 +-Control: BME + not boiled 2 13 0.5 4.5 20
8 +-Control: No BME + boiled 2 13 0 5 20
9 +-Control: No BME + not boiled 2 13 0 5 20
10 Marker 2 0 0 0 2
If no BME is being used, the volume of the lysis and sample buffer will increase.
Protein blotting
30. Prepare 250 ml of 1× PAGE transfer buffer containing 10% methanol (see Recipes).
31. Place the gel in 1× transfer buffer to allow equilibration and washing of the running buffer salts to come off.
32. Soak 2 pieces of filter paper in 1× transfer buffer in a clean container.
33. Soak two sponge pads very thoroughly in 1× transfer buffer in a clean, separate container from everything else.
34. Cut a piece of nitrocellulose membrane to the size of the filter paper and in a third container, soak it in 1× 
transfer buffer. Be sure to nick the upper left hand corner.
35. Place the cathode core (-) side down first on a flat surface. Fill with ~10 ml of 1× transfer buffer.
36. Squeeze one sponge pad to remove excess transfer buffer and place in the cathode core.
37. Place one presoaked piece of filter paper on top of the sponge pad. Use blotting roller to remove any air 
bubbles.
38. Place pretrimmed and rinsed gel carefully on top of the filter paper using the gel knife.
39. Briefly wet the membrane in clean 1× transfer buffer and place over the gel using clean tweezers.
NOTE: Once the membrane is placed the proteins begin to transfer—so try to not move it!
40. Place the second piece of presoaked filter paper on top of the membrane. Use blotting roller to remove any 
air bubbles. Do this carefully to not disrupt the sandwich already built.
41. Squeeze the second sponge pad to remove excess transfer buffer and place in the filter paper.
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42. Place the anode core (+) on top of the sandwich, closing the module.
43. Place the entire module with cathode core (-) facing front into one of the chambers in the mini gel tank. 
Make sure the cassette clamp has been removed after running of the gel.
44. Fill the module core with 1× transfer buffer until the fill line. Do not over fill.
45. Add fresh 1× transfer buffer, about 225 ml, or dH
2
0, to the outside chamber to the cathode on the tank.
46. With the power supply OFF, place lid firmly onto the tank base and plug the electrode cords into the corre-
sponding holes on the power supply (red to red, black to black).
47. Turn ON the power supply and set to a constant voltage of 5 V. Transfer for 150 min.
NOTE: These settings do not apply to every single power supply and gel apparatus. Trial and error with one’s own 
equipment may need to be done.
48. Once the transfer is complete, turn the power supply to OFF.
49. Carefully dissemble the module core using care to not tear the membrane.
50. Using clean tweezers, place the membrane in a clean container with dH
2
0 to rinse for at least 5 min to remove 
any solutions left on from the transfer.
51. To check transfer: cover the entire upper surface of the membrane with Ponceau S staining buffer and incubate 
until bands are visible (approximately 1 min). The Ponceau buffer may be collected and reused up to 10 times.
52. If not done earlier, nick top left corner of membrane with a clean razor and trim excess membrane.
53. Rinse the membrane with 1× HBSS until the background is clean.
54. Wash the membrane twice with distilled water for 5 min while preparing for blocking & incubating.
Membrane blocking & antibody incubation
55. Thaw antibodies on ice.
56. Incubate the membrane with 5 ml blocking buffer for 1 h at 4°C with gentle shaking in a black western 
incubation box. Discard solution.
57. Dilute the primary antibody to the desired concentration in 5 ml blocking buffer. Sigma C2456 primary 
antibody was used at a dilution ratio of 1:2000, equivalent to 2.5 µl C2456 in 5 ml blocking buffer.
58. Incubate the membrane with the diluted primary antibody overnight at 4°C with gentle shaking. Discard 
solution.
59. Wash the membrane 4× for 5 min at room temperature with 15 ml TBST and gentle shaking, discard solution 
after every wash.
60. Dilute the secondary antibody to the desired concentration in 5 ml blocking buffer. This protocol recommends 
using IR-Dye 800 Goat Anti-mouse at a dilution ratio of 1:20000, equivalent to 0.25 µl secondary antibody 
in 5 ml blocking buffer.
61. Incubate the membrane with the diluted secondary antibody for 1 h at room temperature with gentle shaking. 
Discard solution.
62. Wash the membrane 4× for 5 min at room temperature with 15 ml TBST and gentle shaking, discard solution 
after every wash.
63. Discard the last wash and add a little diH
2
O. Membrane is ready to be scanned on the Odyssey Classic In-
frared Imaging System Imager (Protein Visualization).
CRITICAL STEP: Always keep the membrane moist.
OPTIONAL: If a housekeeping gene is needed, after imaging the membrane, repeat steps 56–63, but using an 
IR-Dye 680 to show the loading control in the opposite spectrum. It is also beneficial to use an antibody with a 
species not already used (e.g., if your primary was raised in mouse, now use a loading control raised in rabbit to 
prevent cross-reactivity).
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Immunoprecipitation
Due to the nature of this protocol, two different techniques for recovering the immune complex were done. Both 
were taken from Pierce™ Classic IP Kit (ThermoFisher™) following the manufacturer’s protocol. Optimizations 
are noted here.
NOTE: The muscle lysate used was obtained through our Tissue Homogenization procedure and the lysis buffer is 
described in Recipes. The “IP lysis/wash buffer” provided with the kit was disregarded due to the EDTA component. 
You may use this buffer, however, if EDTA is not a concern.
64. Mammalian cell lysis
64.1. If you have your tissue lysate already, proceed to “Step 65” (as we did), or choose a protocol under 
“Step 64” that fits what type of lysate you are trying to achieve (Protocol I or II).
65. Pre-clear lysate using the control agarose resin
65.1. Instead of 1 mg of lysate, 500 µg of muscle lysate was used. Everything else remained the same.
66. Preparation of immune complex
66.1. For the monoclonal mouse antibody (Sigma) 2µl was loaded into each corresponding tube.
66.2. For the polyclonal rabbit antibody (Abcam) 1 µl was loaded into each corresponding tube.
66.3. 300 µl of our Lysis buffer was used to dilute the antibody/lysate solution.
66.4. Incubation occurred overnight at 4°C.
67. Capture of the Immune complex
67.1. The alternative wash buffer (20× TBS buffer) was used at a 1× concentration (diluted with diH
2
0) 
because detergent-free is important to our samples.
68. Elution of the Immune complex
68.1. The final product from “step 67” was split into 4 tubes to analyze the four different conditions via 
western blotting: Boil/BME, No Boil/BME, Boil/No BME, and No Boil/No BME.
68.2. Sample-buffer elution: Boil/BME conditions were implemented here. BME was used instead of DTT. 
This was performed after the Low-pH elution was done.
68.3. Low-pH elution: No Boil/BME, Boil/No BME, and No Boil/No BME conditions were done using this 
method and 4× Leammli buffer (Bio-Rad) was used. Three elutions were done and the optional step 
of neutralizing each elution with 1 M Tris, pH 9.5 was performed.
Protein visualization
69. Use the Odyssey Classic Infrared Imaging System and Image Studio™ to capture an image of your finished 
membrane. Set conditions to: U 169 µm, Q high, F 0.0 mm, and intensity 5. Clean the surface with diH
2
O 
and wipe with a kimwipe.
70. Place membrane on screen using plastic tweezers.
71. Use mini roller to roll out any air bubbles.
72. Image membrane.
ANTICIPATED RESULTS
When all-native conditions (no boiling, no SDS and no BME) were 
employed for western blot characterization of collagen type 1 in muscle 
tissue lysates, only an unresolved smear above ~240 kDa was detected 
using the Sigma #C2456 antibody in 8% Tris-glycine gels, 6% Tris-gly-
cine gels, or 4%–12% Tris-glycine gels (Fig. 2A, lane 2; Fig. 2B, lane 
2 and 3; Fig. 2C, lane 5). This result suggests that all-native western 
blot conditions are not suitable for the detection of resolved collagen 
type 1 bands. Addition of BME somewhat improved the smear (Fig. 
2C, lane 3), although not sufficiently to detect separate procollagen 
bands. When samples were boiled under these gel conditions, there 
was a loss of detection of any signal using this antibody (Fig. 2A, lane 
1; Fig. 2C, lanes 2 and 4).
We next explored eliminating SDS from 8% Tris-glycine gels (i.e., 
examined this gel type with and without SDS within the gels themselves) 
since SDS dissociation of protein samples can alter disulfide bonds 
and can effect protein migration [12]. We altered typical methods to 
include SDS in sample and running buffers to allow partial denatur-
ation of proteins with the hope of achieving pro- and mature collagen 
1 band detection. When muscle lysates were run on 8% Tris-glycine 
gels without SDS (Fig. 3A), samples that were both boiled and ex-
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posed to BME showed a loss of antibody antigenicity (see Fig. 3A, 
lane 2), supporting the manufacturer’s warning that the Sigma #C2456 
antibody is not suitable for thermally denatured samples. The same 
muscle lysate when boiled with BME showed faint bands of collagen 
cleavage products at ~50 kDa (Fig. 3A, lane 3) representing denatured 
and hydrolyzed collagen polypeptides [13]. The addition of BME to the 
sample in lane 3 reduced the ability to detect procollagen bands above 
~130 kDa observable in lanes 4 and 5 in which no BME was added to 
the muscle lysate. The ~130 kDa bands were also seen in all purified rat 
tail collagen samples (Fig. 3A, lanes 7–10). This molecular weight band 
represents mature collagen a1(I) [3,5,9,10]. However, the boiled sample 
in lane 4 also showed a cleaved protein band at ~50 kDa. In contrast, 
lane 5’s conditions (no boiling and no BME) allowed detection of not 
only the ~130 kDa bands but also a ~250 kDa band that is likely intact 
disulfide-bonded collagen type 1 [7]. This is supported by detection of 
this band in purified rat tail collagen samples in lanes 7–10. Findings 
of lanes 4 and 5, versus lanes 2 and 3, match prior findings that colla-
gen precursors are best visualized in lysates exposed to non-reducing 
conditions [7,14].
Results were similar although less robust in 8% Tris-glycine gels 
with SDS (Fig. 3B and 3C). Exposure of muscle lysates to boiling and 
BME abolished their antigenicity (lane 2 in each figure). Elimination of 
BME allowed detection of mature (~130 kDa) and procollagen bands 
(between 130 kDa and 250 kDa) in lanes 4 and 5. The ~130 kDa and 
~250 kDa bands were also visible in the purified rat tail collagen sam-
ples (Fig. 3B and 3C). No boiling and no BME conditions for muscle 
lysates (lane 5) allowed the best detection of several procollagen bands 
in our 8% Tris-glycine gels with SDS (Fig. 3C) as in 8% Tris-glycine 
gels without SDS (Fig. 3A). However, as a cautionary note, inclusion 
of SDS in these 8% Tris-glycine gels and exposure of samples to either 
BME or boiling lead to increased collagen cleavage products at ~50 
kDa and ~80 kDa in lanes 3–5 of Figure 3B and 3C.
In order to improve the separation of upper molecular weight pro-
collagen bands (~130 and above), we next used 4%–12% Tris-glycine 
gels without SDS, yet again included SDS in the sample and running 
buffers (Fig. 4A). As shown earlier, boiling and BME exposure lead 
to a loss of detection of any bands in muscle lysates (Fig. 4A, lane 2). 
Exposure of these muscle lysates to either BME or boiling, as done for 
lanes 3 and 4, respectively, lead to increased collagen cleavage products 
at ~50 kDa and ~80 kDa. The unboiled, yet BME exposed, muscle lysate 
in lane 3 showed a faint band at ~130 kDa (mature collagen a1(I)) that 
was quite detectable in all purified rat tail collagen samples (lanes 7–10). 
Elimination of BME from muscle lysate preparation for lanes 4 and 5 
increased the ability to detect procollagen bands above ~130 kDa, again 
matching prior findings that collagen precursors are best visualized in 
lysates exposed to non-reducing conditions [7,14]. Conditions of lane 5 
(no boiling and no BME) allowed detection of not only the ~250 kDa, 
but also two procollagen bands at ~180 kDa bands. The acid purified rat 
tail collagen proteins of lanes 7–10 lacked the cleaved mature collagen 
bands seen in muscle lysates in lanes 3 and 4. Structural differences 
can be introduced with different purification/extraction methods that 
are reported to alter antibody binding affinities [15].
Figure 2. Native and modified native western blot results for rat lysates on varying percent Tris-glycine gels. Hindlimb soleus muscle lysates 
were treated with or without boiling, and with or without BME, prior to being run on 8%, 6% or 4%–12% Tris-glycine gels with no SDS in the gels, running 
or sample buffers (2× native sample buffer used). Left blots were probed with anti-collagen type 1 antibodies. Right blots show Ponceau red staining 
of membranes prior to antibody probing. Blots are probed with a Sigma #C2456 anti-collagen 1 antibody. A. 8% Tris-glycine gels with no SDS in gel or 
buffers. Lane 1: Muscle lysate boiled without BME. Lane 2: Muscle lysate that is unboiled and without BME. Lane 3: HiMark unstained protein standard 
as the marker (M). Lane 4: IBright prestained protein ladder. B. 8% Tris-glycine gels with no SDS in gel or buffers. Lane 1: IBright marker. Lanes 2 & 
3: Unboiled muscle lysates without BME. Lane 4: IBright marker. C. 4%–12% Tris-glycine gels with no SDS in gel or buffers. Lanes 1 and 6: HiMark 
unstained protein standard as the marker (M). Lane 2: Muscle lysate boiled with BME. Lane 3: Unboiled muscle lysate with BME. Lane 4: Muscle lysate 
boiled without BME. Lane 4: Unboiled muscle lysate without BME. Gels and blots with no exposure to SDS were repeated 3–4 times per gel type, using 
the same conditions, achieving similar results.
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Results were similar but less robust in 4%–12% bis-Tris gel without 
SDS gels (contain SDS in the sample and running buffers) (Fig. 4B). 
Again, both boiling and BME exposure eliminated antibody detection 
(lane 2). Either boiling or BME (but not both together) increased 
detection of mature (~130 kDa, lane 3) and procollagens (above 130 
kDa, lane 4), but increased cleavage products at ~50 kDa in each lane. 
Eliminating BME allowed resolution and detection of two procollagen 
bands (~180–250; Fig. 4B, lanes 4 and 5). However, as before, more 
procollagen was detected in unboiled muscle lysates than in boiled sam-
ples, each not exposed to BME (Fig. 4B, lane 5 vs. lane 4, respectively).
Lastly, to determine if we could enrich collagen 1 in samples be-
fore immunoblotting, purified rat tail collagen protein samples (PP) 
and muscle lysates (ML) were immunoprecipitated (IP) using either 
polyclonal or monoclonal anti-collagen type 1 antibodies to create the 
immune complex before elution. Figure 5A shows the results for which 
a sample-buffer elution method was used. For this, the spin column 
containing the resin and sample/antibody complex was placed into a new 
collection tube and sample buffer with BME was added. The column 
with the sample immune complex was denatured by boiling and then 
centrifuged to collect the eluant. Samples were then run on 4%–12% 
Tris-glycine gels without SDS. Purified rat tail collagen protein that 
did not undergo IP was loaded into lane 2 (after similar exposure to 
BME and boiling) and showed a clear mature collagen band at ~130 
kDa (matching results from Fig. 4A, lane 7). However, the muscle 
lysate in lane 3 that did not undergo IP showed an absence of this ~130 
band (matching boiled + BME lysate results from Fig. 4A, lane 2). No 
bands were detected in the negative control lanes 4 and 5 (run on the 
columns without capturing primary antibodies). IP with a polyclonal 
anti-rat collagen antibody followed by immunoblotting and probing 
with Sigma #C2456 anti-mouse collagen antibody did not enrich the 
purified rat tail protein (lane 6), but did show enrichment of mature 
collagen (~130 kDa) in the muscle lysate (lane 7). In contrast, IP with 
the Sigma #C2456 anti-mouse collagen antibody followed by immu-
noblotting and probing with a polyclonal anti-rat collagen antibody 
shows non-specific staining only.
Figure 3. Western blot of rat muscle lysates and purified rat tail collagen type 1 protein run under varying conditions on 8% gels without (A) or 
with SDS (B) in the gel, yet with SDS in sample and loading buffers. Hindlimb soleus muscle lysates (Lanes 2–5) and purified rat tail collagen type 
1 (Lanes 7–10) treated with or without boiling, and with or without BME, as shown. Left blots were probed with Sigma C 2456 anti-collagen type 1. Right 
blots show Ponceau red staining of membranes prior to antibody probing. A. Results for an 8% tris-glycine gel without SDS, yet with SDS in the sample 
and running buffers. Lane 1: iBright prestained protein ladder as the marker (M). Lane 2: Muscle lysate boiled with BME. Lane 3: Unboiled muscle lysate 
with BME. Lane 4: Muscle lysate boiled without BME. Lane 5: Unboiled muscle lysate without BME. Lane 6: iBright prestained protein ladder (M). Lane 
7: Purified rat tail protein (Gibco A10483-01) boiled with BME. Lane 8: Unboiled purified rat tail protein with BME. Lane 9: Purified rat tail protein boiled 
without BME. Lane 10: Unboiled purified rat tail protein without BME. Similar 8% gels with no SDS in the gel, yet with SDS in buffers, and subsequent 
blots, were repeated four times, achieving similar results. B and C. Results for an 8% Tris-glycine gel with SDS, and with SDS in the buffers. Lanes 1–10 
were loaded as for panel (A). Similar 8% gels with SDS in the gel and buffer, and subsequent blots, were repeated four times, achieving similar results. 
b-tubulin was used as a loading control (red bands at ~55 kDa) as was ponceau red staining.
J Biol Methods  | 2019 | Vol. 6(3) | e117 11
POL Scientific
Protocol
Figure 4. Western blot of rat muscle lysates and purified rat tail collagen type 1 protein run under varying conditions on 4%–12% Tris-glycine 
gels (A) or 4%–12% Bis-tris gels (B) without SDS, yet with SDS in sample and loading buffers. Hindlimb soleus muscle lysates (Lanes 2–5) and 
purified rat tail collagen type 1 (Lanes 7–10) treated with varying combinations as shown. Left blots were probed with Sigma C 2456 anti-collagen type 
1. Right blots show Ponceau red staining of membranes prior to antibody probing. A. Results for a 4%–12% Tris-glycine gel without SDS, yet with SDS 
in the sample and running buffers. Lane 1: iBright prestained protein ladder as the marker (M). Lane 2: Muscle lysate boiled with BME. Lane 3: Unboiled 
muscle lysate with BME. Lane 4: Muscle lysate boiled without BME. Lane 5: Unboiled muscle lysate without BME. Lane 6: iBright prestained protein 
ladder (M). Lane 7: Purified rat tail protein (Gibco A10483-01) boiled with BME. Lane 8: Unboiled purified rat tail protein with BME. Lane 9: Purified 
rat tail protein boiled without BME. Lane 10: Unboiled purified rat tail protein without BME. Similar gels and subsequent blots were repeated six times, 
achieving similar results. B. Results for a 4%–12% Bis-Tris gel without SDS, yet with SDS in the sample and running buffers. Lanes 1–6 were loaded as 
described for panel (A). Similar gels and subsequent blots were repeated four times, achieving similar results. b-tubulin was used as a loading control 
(red bands at ~55 kDa) as was ponceau red staining.
The IP experiments were repeated using low-pH elution methods in-
stead (Fig. 5B). For these, purified rat tail protein and muscle lysates were 
boiled yet not exposed to BME before running on 4%–12% Tris-glycine 
gels without SDS. Purified rat tail and muscle lysate samples that did 
not undergo IP (Fig. 5B, lanes 2 and 3), showed mature and procollagen 
bands of ~130 kDa and ~250 kDa, respectively, while the muscle lysates 
showed the mature ~130 kDa collagen band, several procollagen bands, 
and a cleavage ~80 kDa product, the latter similar to Figure 4A, lanes 4 
and 9. Negative controls in lanes 4 and 5, run over the column with no 
capturing antibodies, showed an absence of staining. IP did not enrich 
any collagen in the purified rat tail collagen protein sample (lane 6). 
However, a clear enrichment of two high molecular weight procollagens 
(now ~240 kDa) was seen in the muscle lysate that underwent IP with 
an polyclonal anti-rat collagen antibody followed by immunoblotting 
and probing with Sigma #C2456 anti-mouse collagen antibody (lane 
7). IP of each sample type with the Sigma #C2456 anti-mouse collagen 
antibody followed by immunoblotting and probing with a polyclonal 
anti-rat collagen antibody showed similar enrichment of the ~250 kDa 
band in both sample types (Fig. 5B, lanes 9 and 10). For the other two 
conditions, Boil/No BME and No Boil/No BME, no enrichment was 
detected using either elution method (data not shown).
As summarized in Table 2, the best resolution of type 1 procollagens 
is achieved using 4%–12% Tris-glycine gels without the presence of 
SDS in the gel itself, although SDS in the running and sample buffers 
are needed. Also, BME must not be added to the sample buffer and 
samples should not be boiled. For characterization of mature collagen 
a1(I), gradient type gels without SDS were best, yet SDS included in 
both running and sample buffers, BME must be added to the sample 
buffer, and samples should not be boiled. Boiling is to be avoided as the 
antigen site recognized by the monoclonal antibody used is sensitive to 
thermal denaturation, as is the case with many monoclonal antibodies 
available on the market.
TROUBLESHOOTING
Many problems can occur when performing Western blotting. Listed 
in Table 3 are possible troubleshooting explanations and solutions one 
can use.
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Figure 5. Western blot of rat skeletal muscle lysates and purified rat tail collagen type 1 protein after immunoprecipitation (IP) of immune com-
plex using sample-buffer elution method (A) or low-pH elution method (B). Immunoprecipitation elutions of hindlimb soleus muscle lysates (ML; 1 
µl/lane, Lanes 5, 7 and 10) and purified rat tail collagen type 1 protein (PP; 1µL/lane, Lanes 4, 6, and 9). Left blots were probed with anti-collagen type 1 
antibodies. Right blots show Ponceau red staining of membranes prior to antibody probing. For each repeat, 4%–12% Tris-glycine gels were used. A. A 
sample-buffer elution method was used to recover the immune complex (a 2× reducing sample buffer with BME was added to Protein A/B Plus Agarose 
resin that was then boiled before centrifugation to remove the eluate). Lanes 1 and 8: iBright prestained protein ladder as the marker (M). Lanes 2 and 
3: PP and ML samples were loaded onto the gels without first undergoing IP. The membrane portion with these lanes was probed with Sigma C 2456 
anti-mouse collagen type 1. Lanes 4 and 5: As a negative control step, PP and ML were added to the column without addition of any antibody (i.e., no 
IP). Samples were collected as flow-through. After western blotting, the membrane portion with these lanes was probed with the Sigma C 2456 antibody. 
Lanes 6 and 7: Samples were immunoprecipitated with Abcam Ab34710 anti-rabbit collagen type 1. After western blotting, membrane portion with these 
lanes was probed with the Sigma C 2456 antibody. Lanes 8 and 9: Samples were immunoprecipitated with the Sigma C 2456 antibody. After western 
blotting, membrane portion with these lanes was probed with the Abcam Ab34710 antibody. B. A low-pH elution method was used to recover the immune 
complex in this set of experiments. Lanes 1–10 were loaded as described above.
Table 2. Optimal conditions for visualization of various collagen type 1 bands in skeletal muscle.
Collagen type 1
Disulfide bonded collagen 1/Intact triple helix
(~250 + kDa)
• 4%–12% Tris-glycine gel
• No SDS in gel
• Not boiled
• No BME
• No SDS in Tris-glycine running buffer
• No SDS in sample buffer
Procollagen I subtypes
(~180 to 200 kDa)
• 4%–12% tris-glycine gel
• No SDS in gel
• Best not boiled
• No BME
• SDS in Tris-glycine running buffer
• SDS in 4× Laemmli sample buffer
Mature collagen α1 (I)
(~130 kDa)
• If a 4%–12% Tris-glycine gel
• No SDS in gel
• Boiling optional
• BME
• SDS in Tris-glycine running buffer
• SDS in 4× Laemmli sample buffer
Mature collagen α1 (I)
(~130 kDa)
• If a 4%–12% bis-Tris gel
• No SDS in gel
• Not boiled
• BME
• SDS in Tris-glycine running buffer
• SDS in 4× Laemmli sample buffer
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Table 3. Troubleshooting table.
Problem Possible explanation Solution
No signal Concentration of the primary or secondary antibody 
is too weak
Use a higher concentration of primary antibody—success has 
been demonstrated with Sigma #C 2456 at a dilution ratio of 
1:1000–1:2000
  Insufficient antigen This protocol recommends loading 20 μg of total protein per 
well, but up to 30 μg should work; if collagen bands still do not 
present, it is possible that the tissue itself does not contain 
substantial amounts of collagen
  Poor transfer of collagen to nitrocellulose mem-
brane
A longer transfer with a lower voltage can be used
High background Insufficient blocking of membrane Optimal blocking of non-specific binding was demonstrated 
using 5% BSA in TBST, but goat milk serum may also be used
  Primary antibody concentration was too high Decrease the dilution ratio of the antibody and incubate for 
longer
  Incubation temperature is too high Incubate the membrane in blocking buffer and primary antibody 
at 4°C
  Secondary antibody is giving unexpected bands Make sure a secondary only probing is done without primary 
antibody to verify that the bands are not due to secondary anti-
body nonspecific binding
  Intensity is turned up too high on the Licor Imager Reduce the intensity so that the background is reduced; if the 
intensity is too high background bands, spots, etc., can start to 
appear
White spots on the blot Trapped air bubbles during transfer Make sure to use a mini-blot roller to carefully remove bubbles 
when assembling the transfer
  Overheating during transfer Place gel tank in ice or in a coldroom for the duration of the 
transfer; and or reduce the voltage and increase transfer time
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